Grifols: the board considers that Brookfield’s indicative price undervalues the company Teva: S&P upgrades the rating to BB/positive from BB/positiveElior: Results recovered in 2023-24, exceeding expectations. Debt reduction is making headway as planned.Tereos: Sharp decline in EBITDA in Q2 24/25. The financial position is stable thanks to the generation of FCF.>...
Grifols : le conseil d’administration estime que le prix indicatif proposé par Brookfield sous-évalue la sociétéTeva: S&P upgrades the rating to BB/positive from BB/positiveElior: les résultats se sont redressés 2023/24, dépassant les attentes. Le désendettement progresse comme prévu.Tereos : fort repli de l'EBITDA au T2 24/25. La situation financière est stable grâce à la génération de FCF.>...
A director at Bayer AG bought 11,278 shares at 20.745EUR and the significance rating of the trade was 73/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly show...
>Group’s adj. EBITDA significantly below expectations - At a group level, Bayer’s Q3 sales of € 9.97bn (-3.6%), were below our (€ 10.2bn) and consensus estimates (€ 10.1bn), the group’s EBITDA of € 1,251m (-26%) came in 9% weaker than we expected (€ 1,376m) and was 5% below the consensus (€ 1,313m). The significant group’s EBITDA decline vs Q3 2023 was driven by the Pharma division, which came in at € 1,102m (23.4% below Q3 2023). Adjusted EPS of € 0.24 was 37% below ...
Rdos. 3T'24 vs 3T'23: Ventas: 9.968 M euros (-3,6% vs -1,7% BS(e) y -2,2% consenso); EBITDA: 1.251 M euros (-25,8% vs -18,0% BS(e) y -22,1% consenso). Rdos. 9meses'24 vs 9meses'23: Ventas: 34.877 M euros (-2,5% vs -2,0% BS(e) y -2,1% consenso); EBITDA: 7.774 M euros (-10,5% vs -9,0% BS(e) y -9,8% consenso).
COMPAÑÍAS QUE APARECEN EN EL INFORME: ESPAÑA: BANKINTER, CAIXABANK, MINOR HOTELS, SECTOR INMOBILIARIO, SECTOR SEGUROS. EUROPA: BAYER. Incluido en el informe diario de hoy, y durante toda la campaña de resultados, incorporamos al final una presentación con los resultados destacados en positivo y negativo y previews de Rdos. 3T’24 que se publicarán en España y Europa en los próximos días. Los mercados se estabilizan En una jornada de pocos catalizadores las bolsas europeas rebotaron, compensand...
Market Update - Bull SA issues preferred share to the French State to protect national interests in relation to sovereign sensitive activities carried out by Atos Press Release Market update Bull SA issues preferred share to the French State to protect national interests in relation to sovereign sensitive activities carried out by Atos Paris, France – November 8, 2024 – Further to the agreement announced on June 26, 2024 between Atos SE (“Atos”), Bull SA and the French State, Atos announces that Bull SA has issued today a preferred share (action de préférence) for the benefit of the Fren...
Point de Marché - Emission par Bull SA d’une action de préférence au profit de l’Etat français dans le cadre des droits de protection accordés à l’Etat français sur les activités souveraines et sensibles Communiqué de presse Point de marché Emission par Bull SA d’une action de préférence au profit de l’Etat français dans le cadre des droits de protection accordés à l’Etat français sur les activités souveraines et sensibles Paris, France – 8 Novembre 2024 – Dans le prolongement de la convention conclue entre Atos SE (« Atos »), Bull SA et l’Etat français le 26 juin 2024, Atos annonce que ...
>Atos launches the € 233m capital increase dedicated to shareholders, with preferential subscription rights … - Atos announces this morning the launch of a capital increase with preferential subscription rights for shareholders, for a gross amount, including issue premium, of € 233.3m through the issuance of 63.06bn new shares, with a subscription price of € 0.0037 per new share (i.e. 13,497 new shares for 24 existing shares) and a subscription period from 14 November...
>Atos launches the € 233m capital increase dedicated to shareholders, with preferential subscription rights … - Atos announces this morning the launch of a capital increase with preferential subscription rights for shareholders, for a gross amount, including issue premium, of € 233.3m through the issuance of 63.06bn new shares, with a subscription price of € 0.0037 per new share (i.e. 13,497 new shares for 24 existing shares) and a subscription period from 14 November...
Availability of an Amendment to the 2023 Universal Registration Document Availability of an Amendment to the 2023 Universal Registration Document Bezons, November 8, 2024 Atos S.E. (the “Company” or “Atos”) announces that an amendment to the 2023 Universal Registration Document was filed on November 7, 2024, with the French Financial Markets Authority (Autorité des Marchés Financiers) under number D.24-0429-A01. This amendment is part of the prospectus approved on November 7, 2024 by the French Financial Markets Authority under reference number 24-474 for the purposes of the share cap...
Mise à disposition d’un Amendement au Document d’Enregistrement Universel 2023 Mise à disposition d’un Amendement auDocument d’Enregistrement Universel 2023 Bezons, le 8 novembre 2024 Atos S.E. (la « Société » ou « Atos ») annonce avoir déposé le 7 novembre 2024, auprès de l’Autorité des Marchés Financiers un amendement à son Document d’Enregistrement Universel 2023 sous le numéro D.24-0429-A01. Cet amendement fait partie du prospectus approuvé le 7 novembre 2024 par l’Autorité des Marchés Financiers sous le numéro 24-474 pour les besoins de l’augmentation de capital avec maintien du dr...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.